Xiaofu Zhu

发表

Are adjuvant bisphosphonates now standard of care of women with early stage breast cancer? A debate from the Canadian Bone and the Oncologist New Updates meeting

M. Clemons, E. Amir, A. Paterson, 2015, Journal of bone oncology.

Simplified guideline for prescribing medical cannabinoids in primary care.

G. M. Allan, Christina S Korownyk, M. Kolber, 2018, Canadian family physician Medecin de famille canadien.

Radical Treatment of Stage II Non–small‐cell Lung Cancer With Nonsurgical Approaches: A Multi‐institution Report of Outcomes

J. Pantarotto, N. Leighl, P. Wheatley‐Price, 2018, Clinical lung cancer.

Bone-targeted therapy for metastatic breast cancer—Where do we go from here? A commentary from the BONUS 8 meeting

M. Clemons, C. Addison, E. Amir, 2014, Journal of bone oncology.

Comparing docosahexaenoic acid (DHA) concomitant with neoadjuvant chemotherapy versus neoadjuvant chemotherapy alone in the treatment of breast cancer (DHA WIN): protocol of a double-blind, phase II, randomised controlled trial

K. Courneya, J. Mackey, Sunita Ghosh, 2019, BMJ Open.

Rationale and design of the Diet Restriction and Exercise-induced Adaptations in Metastatic breast cancer (DREAM) study: a 2-arm, parallel-group, phase II, randomized control trial of a short-term, calorie-restricted, and ketogenic diet plus exercise during intravenous chemotherapy versus usual care

Richard B. Thompson, K. Courneya, J. Mackey, 2021, BMC Cancer.

Phylogenetic analysis of classical swine fever virus isolates from China

Xiaofu Zhu, Wentao Ma, Mingjie Liu, 2021, Archives of Virology.

How Canadian Oncologists Use Oncotype DX for Treatment of Breast Cancer Patients

Tinghua Zhang, S. Dent, Xiaofu Zhu, 2021, Current oncology.

Factors influencing Oncotype DX use in the management of early breast cancer: a single centre experience.

Tinghua Zhang, S. Dent, Xiaofu Zhu, 2014, European journal of cancer.

Approach to the non-operative management of patients with stage II non-small cell lung cancer (NSCLC): A survey of Canadian medical and radiation oncologists.

J. Pantarotto, N. Leighl, P. Wheatley‐Price, 2016, Lung cancer.

Targeting HER2 in Advanced Breast Cancer.

A. Joy, Xiaofu Zhu, 2017, Methods in molecular biology.

Cost effectiveness vs. affordability in the age of immuno-oncology cancer drugs

G. Dranitsaris, M. Vincent, G. Adunlin, 2018, Expert review of pharmacoeconomics & outcomes research.

A multi-centre study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of docetaxel-cyclophosphamide induced febrile neutropenia

G. Pond, J. Mackey, B. Hutton, 2021, Breast.

Feasibility of using a pragmatic trials model to compare two primary febrile neutropenia prophylaxis regimens (ciprofloxacin versus G-CSF) in patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer (REaCT-TC)

B. Hutton, M. Clemons, D. Fergusson, 2018, Supportive Care in Cancer.

Systemic toxicities of trastuzumab‐emtansine predict tumor response in HER2+ metastatic breast cancer

W. Hillegass, Shou-Ching Tang, Xiaofu Zhu, 2021, International journal of cancer.

A Bayesian network meta-analysis on second-line systemic therapy in advanced gastric cancer

Kelvin K. W. Chan, S. Berry, Y. Ko, 2017, Gastric Cancer.

Neoadjuvant treatments for locally advanced, resectable esophageal cancer: A network meta‐analysis

Kelvin K. W. Chan, R. Wong, Xiaofu Zhu, 2018, International journal of cancer.

Canadian quality indicators for percutaneous coronary interventions.

J. Tu, H. Wijeysundera, J. Richards, 2008, The Canadian journal of cardiology.

Development and validation of a novel anoikis-related gene signature for predicting prognosis in ovarian cancer

Lina Mei, Xiaofu Zhu, Shuangfeng Qian, 2023, Aging.